Candidacy assessment
Your provider reviews the condition, prior care, health history, and whether a regenerative approach is medically reasonable.
Regenerative medicine is a broad category, and not every treatment promoted under that label has the same evidence or regulatory status. We begin with your goals, condition, history, and an honest discussion of appropriate options.

Regenerative approaches vary considerably. Depending on the issue, the most appropriate path may include conventional treatment, rehabilitation, referral, or a carefully selected procedure. No specific regenerative product or biologic is implied by this page.
Your provider reviews the condition, prior care, health history, and whether a regenerative approach is medically reasonable.
Potential options should be compared with established treatments, rehabilitation, referral, and watchful waiting where appropriate.
Any procedure or biologic treatment should include a clear explanation of limitations, adverse effects, expected outcomes, and regulatory status.
Identify what is limiting you, what has already been tried, and what outcome you are hoping to achieve.
A clinician determines whether further imaging, referral, rehabilitation, or a regenerative option is appropriate.
Proceed only with a plan whose evidence, risks, and alternatives are clear enough for informed consent.
This page does not claim any specific stem-cell or biologic product. Exact regenerative services and availability should be confirmed directly with the clinical team.
No. Evidence varies by treatment and condition, and some approaches remain investigational.
Possibly. Your clinician may recommend imaging, rehabilitation, orthopedic evaluation, or another specialist depending on the concern.
Not necessarily. Some conditions may still require conventional treatment or surgical evaluation.
Call (480) 485-4590 to ask about availability, candidacy, and the right first visit for you.
Regenerative medicine includes treatments with very different evidence and regulatory profiles. Some marketed biologic or cell-based therapies may be investigational or not FDA-approved for a proposed use. Treatment recommendations require clinician evaluation, informed consent, and discussion of appropriate alternatives.